Source: International Congress 2018 – COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Chermiti Ben Abdallah (Ariana, Tunisia), M. Kacem (Ariana, Tunisia), I. Bachouch (Ariana, Tunisia), N. Belloumi (Ariana, Tunisia), Y. Hdidene (Ariana, Tunisia), S. Fenniche (Ariana, Tunisia). Pharmacological treatment of stable Chronic Obstructive Pulmonary Disease: Where do we stand?. 4382

Member's Comments

No comment yet.

Related content which might interest you: Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Airway infection in COPD Year: 2019 Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Development of the TANDEM intervention for Chronic Obstructive Pulmonary Disease: reporting on the pre-pilot phase Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Bone demineralization in Chronic Obstructive Pulmonary Disease: is there an impact? Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Chronic Obstructive Pulmonary Disease: A Forgotten Killer Source: Eur Respir J 2009; 33: 456 Year: 2009 A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Nutritional Disorders of Patients with Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019 Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Level of control of Chronic Obstructive Pulmonary Disease according to clinical phenotypes. Study SINCON Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017